Jazz Pharmaceuticals PLC (United States) is listed on the Nasdaq and has a market capitalization of $15.06 billion, with shareholders equity totaling $4.19 billion.
The company employs approximately 1.620 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Jazz Pharmaceuticals PLC reported $4.72 billion in revenue, generating net income of $205.95 million.
Key financial metrics include a P/E ratio of 73.15, a price-to-book (P/B) ratio of 3.59, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker JAZZ.